126 related articles for article (PubMed ID: 33745679)
1. Incidence and dynamic risk stratification in differentiated thyroid cancer in a high-resolution clinic, 2002-2017.
Díaz-Soto G; Torres Torres B; López JJ; García S; Álvarez Quiñones M; de Luis D
Endocrinol Diabetes Nutr (Engl Ed); 2021 Mar; ():. PubMed ID: 33745679
[TBL] [Abstract][Full Text] [Related]
2. Incidence and dynamic risk stratification in differentiated thyroid cancer in a high-resolution clinic, 2002-2017.
Díaz-Soto G; Torres BT; López JJ; García S; Quiñones MÁ; de Luis D
Endocrinol Diabetes Nutr (Engl Ed); 2021 Nov; 68(9):636-641. PubMed ID: 34906344
[TBL] [Abstract][Full Text] [Related]
3. Evolution of suppressing TSH therapy at diagnosis and in the long-term follow-up in a cohort of differentiated thyroid cancer.
Díaz-Soto G; Fernández-Velasco P; Torres Torres B; López Gómez JJ; García Calvo S; de Luis Román D
Endocrinol Diabetes Nutr (Engl Ed); 2022 Dec; 69(10):844-851. PubMed ID: 36470820
[TBL] [Abstract][Full Text] [Related]
4. Natural Course of the American Thyroid Association Response to Therapy Statuses (Dynamic Risk Stratification) in Differentiated Thyroid Cancer.
Mukhtar N; Aljamei H; Aljomaiah A; Moria Y; Alzahrani AS
Eur Thyroid J; 2021 Jun; 10(3):198-207. PubMed ID: 34178705
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Risk Stratification in the Follow-Up of Children and Adolescents with Differentiated Thyroid Cancer.
Zanella AB; Scheffel RS; Nava CF; Golbert L; Laurini de Souza Meyer E; Punales M; Gonçalves I; Dora JM; Maia AL
Thyroid; 2018 Oct; 28(10):1285-1292. PubMed ID: 30129889
[TBL] [Abstract][Full Text] [Related]
6. Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy.
Park S; Kim WG; Song E; Oh HS; Kim M; Kwon H; Jeon MJ; Kim TY; Shong YK; Kim WB
Thyroid; 2017 Apr; 27(4):524-530. PubMed ID: 27869547
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
8. Thyroid lobectomy in patients with differentiated thyroid cancer: an analysis of the clinical outcomes in a nationwide multicenter study.
Díez JJ; Alcázar V; Iglesias P; Romero-Lluch A; Sastre J; Corral BP; Zafón C; Galofré JC; Pamplona MJ
Gland Surg; 2021 Feb; 10(2):678-689. PubMed ID: 33708550
[TBL] [Abstract][Full Text] [Related]
9. Applicability of Adults 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines for Postoperative Risk Stratification and Postradioiodine Treatment Dynamic Risk Stratification in Pediatric Population.
Singh SS; Mittal BR; Sood A; Bhattacharya A; Kumar G; Shekhawat AS; Singh H
World J Nucl Med; 2022 Jun; 21(2):127-136. PubMed ID: 35865163
[No Abstract] [Full Text] [Related]
10. Incomplete response to therapy in intermediate- and high-risk thyroid cancer.
Alzahrani AS; Mukhtar N
Endocrine; 2022 Dec; 78(3):531-542. PubMed ID: 36074242
[TBL] [Abstract][Full Text] [Related]
11. Modified dynamic risk stratification for predicting recurrence using the response to initial therapy in patients with differentiated thyroid carcinoma.
Jeon MJ; Kim WG; Park WR; Han JM; Kim TY; Song DE; Chung KW; Ryu JS; Hong SJ; Shong YK; Kim WB
Eur J Endocrinol; 2014 Jan; 170(1):23-30. PubMed ID: 24088549
[TBL] [Abstract][Full Text] [Related]
12. Response to Therapy Status Is an Excellent Predictor of Pregnancy-Associated Structural Disease Progression in Patients Previously Treated for Differentiated Thyroid Cancer.
Rakhlin L; Fish S; Tuttle RM
Thyroid; 2017 Mar; 27(3):396-401. PubMed ID: 27835925
[TBL] [Abstract][Full Text] [Related]
13. Differentiated Thyroid Cancer in a Pediatric Population: Estimating the Risk of Recurrence and Evolution Over Time.
Damásio I; Dias D; Pinheiro S; Esteves S; Leite V; Santos R
Cureus; 2023 Jan; 15(1):e34313. PubMed ID: 36860222
[TBL] [Abstract][Full Text] [Related]
14. Modified dynamic risk stratification system further predicts individual outcome in patients with intermediate-risk papillary thyroid cancer.
Cuéllar DI; De Los Reyes A; Llamas-Olier A
Ann Endocrinol (Paris); 2023 Apr; 84(2):242-248. PubMed ID: 35483449
[TBL] [Abstract][Full Text] [Related]
15. Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
Grani G; Zatelli MC; Alfò M; Montesano T; Torlontano M; Morelli S; Deandrea M; Antonelli A; Francese C; Ceresini G; Orlandi F; Maniglia CA; Bruno R; Monti S; Santaguida MG; Repaci A; Tallini G; Fugazzola L; Monzani F; Giubbini R; Rossetto R; Mian C; Crescenzi A; Tumino D; Pagano L; Pezzullo L; Lombardi CP; Arvat E; Petrone L; Castagna MG; Spiazzi G; Salvatore D; Meringolo D; Solaroli E; Monari F; Magri F; Triggiani V; Castello R; Piazza C; Rossi R; Ferraro Petrillo U; Filetti S; Durante C
Thyroid; 2021 Feb; 31(2):264-271. PubMed ID: 32475305
[No Abstract] [Full Text] [Related]
16. Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer.
Sung TY; Jeon MJ; Lee YH; Lee YM; Kwon H; Yoon JH; Chung KW; Kim WG; Song DE; Hong SJ
J Clin Endocrinol Metab; 2017 Mar; 102(3):793-800. PubMed ID: 27809646
[TBL] [Abstract][Full Text] [Related]
17. Follow-up strategy of radiofrequency ablation for papillary thyroid microcarcinoma: defining a response-to-ablation system.
Li X; Yan L; Xiao J; Li Y; Yang Z; Zhang M; Luo Y
Eur Radiol; 2024 Feb; 34(2):761-769. PubMed ID: 37597031
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of thyroid cancer in Navarra (Spain). Evolution and clinical characteristics, 1986-2010.
Rojo Álvaro J; Bermejo Fraile B; Menéndez Torre E; Ardanaz E; Guevara M; Anda Apiñániz E
Endocrinol Diabetes Nutr; 2017; 64(6):303-309. PubMed ID: 28604340
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of dynamic risk stratification in pediatric patients with differentiated thyroid carcinoma.
Kim K; Kim WW; Choi JB; Kim MJ; Lee CR; Lee J; Kang SW; Nam KH; Chung WY; Jeong JJ
Ann Surg Treat Res; 2018 Oct; 95(4):222-229. PubMed ID: 30310805
[TBL] [Abstract][Full Text] [Related]
20. Acromegaly and thyroid cancer: analysis of evolution in a series of patients.
Danilowicz K; Sosa S; Gonzalez Pernas MS; Bamberger E; Diez SM; Fainstein-Day P; Furioso A; Glerean M; Guitelman M; Katz D; Lemaitre N; Lowenstein A; Del Valle Luna M; Martínez MP; Miragaya K; Moncet D; Ortuño MV; Pignatta A; Ramacciotti CF; Reyes A; Rogozinski AS; Slavinsky P; Tkatch J; Pitoia F
Clin Diabetes Endocrinol; 2020 Nov; 6(1):24. PubMed ID: 33292786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
